Your browser doesn't support javascript.
loading
Brentuximab vedotin and anti-PD1 treatment optimize survival in chemo-refractory Hodgkin lymphoma patients: Real-world data.
Sakellari, Ioanna; Gavriilaki, Eleni; Iskas, Michail; Bousiou, Zoi; Chatziioannidis, Aristotelis; Batsis, I; Mallouri, Despina; Constantinous, Varnavas; Stavroyianni, Niki; Syrigou, Antonia; Marvaki, Anastasia; Pilavaki, Maria; Papaemmanouel, Styliani; Anagnostopoulos, Achilles.
  • Sakellari I; Hematology Department-BMT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
  • Gavriilaki E; Hematology Department-BMT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
  • Iskas M; Hematology Department-BMT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
  • Bousiou Z; Hematology Department-BMT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
  • Chatziioannidis A; Hematology Department-BMT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
  • Batsis I; Hematology Department-BMT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
  • Mallouri D; Hematology Department-BMT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
  • Constantinous V; Hematology Department-BMT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
  • Stavroyianni N; Hematology Department-BMT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
  • Syrigou A; Hematology Department-BMT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
  • Marvaki A; Hematology Department-BMT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
  • Pilavaki M; Radiology Department, G. Papanicolaou Hospital, Thessaloniki, Greece.
  • Papaemmanouel S; PathologyDepartment, G. Papanicolaou Hospital, Thessaloniki, Greece.
  • Anagnostopoulos A; Hematology Department-BMT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
Hematol Oncol ; 37(4): 490-492, 2019 Oct.
Article en En | MEDLINE | ID: mdl-31339579
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article